AGP Picks
View all

The Boston Examiner
Provided by AGP

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on June 10, 2026

Hi Marley Unveils Vision for the Intelligent Communication Platform for P&C Insurance
Jun. 10, 2026

Hi Marley Unveils Vision for the Intelligent Communication Platform for P&C Insurance

Indeterminate GlobeNewswire
Stran & Company Secures New Contract with Leading Construction Solutions Provider
Jun. 10, 2026

Stran & Company Secures New Contract with Leading Construction Solutions Provider

Indeterminate GlobeNewswire
Maestra's Service-as-a-Software Model Accelerates Across E-Commerce
Jun. 10, 2026

Maestra's Service-as-a-Software Model Accelerates Across E-Commerce

Indeterminate GlobeNewswire
Akebia Therapeutics Strengthens Vafseo® (vadadustat) Patent Portfolio
Jun. 10, 2026

Akebia Therapeutics Strengthens Vafseo® (vadadustat) Patent Portfolio

Indeterminate GlobeNewswire
Parexel to Showcase Seven Research Posters and Debut New Hematology Playbook at the European Hematology Association Congress 2026
Jun. 10, 2026

Parexel to Showcase Seven Research Posters and Debut New Hematology Playbook at the European Hematology Association Congress 2026

Indeterminate GlobeNewswire
Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases
Jun. 10, 2026

Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases

Indeterminate GlobeNewswire
CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies
Jun. 10, 2026

CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies

Indeterminate GlobeNewswire
Ethyreal Bio Emerges from Stealth with $101 Million in Financing to Advance ETHY-001, a Potentially Best-in-Class Anti-TSHR Antibody for Thyroid Eye Disease and Graves’ Disease
Jun. 10, 2026

Ethyreal Bio Emerges from Stealth with $101 Million in Financing to Advance ETHY-001, a Potentially Best-in-Class Anti-TSHR Antibody for Thyroid Eye Disease and Graves’ Disease

Indeterminate GlobeNewswire
Akamai Earns the Solutions Partner with Certified Software Designation for Security
Jun. 10, 2026

Akamai Earns the Solutions Partner with Certified Software Designation for Security

Indeterminate GlobeNewswire
Sameer Kanodia Receives India’s Top 50 CEOs, MDs, and Founders Recognition by Great Manager Institute® for the 2nd Consecutive Year in 2026
Jun. 10, 2026

Sameer Kanodia Receives India’s Top 50 CEOs, MDs, and Founders Recognition by Great Manager Institute® for the 2nd Consecutive Year in 2026

Indeterminate GlobeNewswire
JA Worldwide and IBM Expand Global Collaboration with Goal of Delivering AI and Digital Skills to Up to One Million High-School Students
Jun. 10, 2026

JA Worldwide and IBM Expand Global Collaboration with Goal of Delivering AI and Digital Skills to Up to One Million High-School Students

Indeterminate GlobeNewswire
Imprivata, leader nelle soluzioni di gestione degli accessi, entra nel mercato italiano per supportare le organizzazioni sanitarie a migliorare la sicurezza senza rallentare la produttività
Jun. 10, 2026

Imprivata, leader nelle soluzioni di gestione degli accessi, entra nel mercato italiano per supportare le organizzazioni sanitarie a migliorare la sicurezza senza rallentare la produttività

Indeterminate GlobeNewswire
Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering
Jun. 10, 2026

Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering

Indeterminate GlobeNewswire
Parabilis Medicines Announces Pricing of Upsized Initial Public Offering
Jun. 10, 2026

Parabilis Medicines Announces Pricing of Upsized Initial Public Offering

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.